Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the …
![Mino-Lok Phase 3 Trial - Enrollment Completion](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/01/pexels-pixabay-139398.jpg?resize=760%2C427&ssl=1)
![Mino-Lok Phase 3 Trial - Enrollment Completion](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/01/pexels-pixabay-139398.jpg?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the …